Clorazepate Dipotassium Tablet
Product Images NDC 70954-158

7 FDA label images from Ani Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 70954-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of clorazepate dipotassium showing the molecular arrangement including a chlorinated benzodiazepine core, a carboxylate group with potassium and potassium hydroxide components, and other key functional groups represented by standard chemical notation.*
FDA Label Image

Blister One (Blister 1)

Blister One (Blister 1)
Blister card packaging label for Clorazepate Dipotassium 3.75 mg tablets, USP. The label includes multiple tablet compartments arranged in a row with peelable sections marked "PEEL HERE." Each section indicates the active ingredient and strength, with a barcode, lot number, expiration date placeholders, and manufacturing information by Novitium Pharma LLC, East Windsor, NJ.*
FDA Label Image

Carton One (Carton 1)

Carton One (Carton 1)
Packaging label for Clorazepate Dipotassium Tablets, USP 3.75 mg oral tablets. The label shows a unit-dose package containing 30 tablets (3 x 10 units). The product is marked for prescription use only and includes medication guide dispensing instructions. The labeler is Novitium Pharma LLC, with an address in East Windsor, New Jersey.*
FDA Label Image

Blister-2 (Blister 2)

Blister-2 (Blister 2)
Clorazepate Dipotassium 7.5 mg oral tablets packaging label from Novitium Pharma LLC, East Windsor, NJ. The label includes multiple peel tabs with black and white barcodes, the drug name, dosage strength, and placeholder text for expiration date and lot number. Each panel states 'Clorazepate Dipotassium Tablet, USP' along with a Roman numeral IV.*
FDA Label Image

Carton Two (Carton 2)

Carton Two (Carton 2)
Packaging label for Clorazepate Dipotassium Tablets, USP 7.5 mg oral tablets by Novitium Pharma. The label indicates a unit-dose pack containing 30 tablets (3 x 10). It includes dosage strength, NDC 70954-158-50, pharmacist dispensing instructions, storage and handling information, and manufacturer details for Novitium Pharma LLC, East Windsor, New Jersey.*
FDA Label Image

Blister-3 (Blister 3)

Blister-3 (Blister 3)
Label for Clorazepate Dipotassium tablet USP 15 mg from Novitium Pharma LLC, East Windsor, NJ. The label includes multiple identical repeating sections with a 15 mg strength prominently displayed, barcodes, expiration and lot placeholders, and a peel here section, all arranged in a pattern for a multi-dose or blister package.*
FDA Label Image

Carton Three (Carton 3)

Carton Three (Carton 3)
Packaging label for Clorazepate Dipotassium Tablets, USP 15 mg. The label shows a unit-dose tablet pack of 30 tablets (3 x 10 count) by Novitium Pharma. The label includes storage instructions, pharmacist dispensing guidance, and manufacturer details for Novitium Pharma LLC, East Windsor, New Jersey.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.